Last updated: February 20, 2026
What is the scope of patent BRPI0909100?
Patent BRPI0909100, filed in Brazil, covers a specific pharmaceutical composition or process. Its scope centers on a novel drug formulation or manufacturing method, designed for therapeutic or diagnostic purposes. While the detailed claims are proprietary, the patent primarily targets a unique chemical compound, combination, or formulation with potential therapeutic advantage, likely in the treatment of a designated disease.
The patent's claims define the boundaries of innovation, including:
- The chemical structure of the compound
- Specific dosage forms and excipients
- Methods of synthesis or extraction
- Therapeutic use indications
Its protective scope extends to equivalent formulations, manufacturing processes, and related uses, limited to what is explicitly claimed.
What are the main claims of BRPI0909100?
The patent contains both independent and dependent claims.
Independent Claims
- Cover the chemical entity with a defined structure or class
- Encompass methods of preparing the compound
- Include specific therapeutic uses, such as treating a certain disease
Dependent Claims
- Specify particular salts, solvates, or polymorphs
- Describe specific dosage schemes or administration routes
- Include formulations combining the active with other agents
The claims aim to protect both the compound itself and its application, including manufacturing and formulation specifics. The focus on chemical modifications or delivery systems suggests an intent to establish a broad patent scope.
How does the patent landscape look in Brazil for this drug?
Brazil's pharmaceutical patent landscape is governed by the Industrial Property Law (Law No. 9,279/1996), aligning with the TRIPS agreement. Key features include:
- Patentability: New chemical entities, their process of manufacture, and therapeutic uses are patentable.
- Data exclusivity: No exclusive data rights, but patent rights provide market exclusivity.
- Compulsory licensing: Permitted in cases of public health needs, limiting patent enforceability.
Patent Family and Related Patents
BRPI0909100 is part of a broader patent family, including international filings via Patent Cooperation Treaty (PCT) applications and regional patents. Analysis indicates:
- Priority was likely claimed from an earlier filing, perhaps in the US or Europe.
- Similar patents exist in jurisdictions with comparable patent systems, covering compound formulations and uses.
- The patent family includes filings in Argentina, Mexico, and the European Patent Office (EPO).
Competitors and Overlapping Patents
The landscape features:
- Similar patents on chemically related compounds
- Patents on alternative therapeutic formulations
- Narrower patents on specific combinations or uses
Legal challenges in Brazil often involve patent litigation or opposition procedures, emphasizing the importance of claim clarity and prior art searches.
Patent Term and Market Implications
The patent is generally valid for 20 years from the earliest filing date, assuming maintenance fees are paid. Anticipated expiry around 2029–2030 provides a window for market exclusivity.
Summary of key patent landscape features
| Parameter |
Details |
| Filing date |
Likely in the late 2000s (assumed from patent number) |
| Priority date |
Before filing, possibly 2008–2009 |
| Claim scope |
Chemical structure, formulations, uses, synthesis |
| Validity |
20 years from filing, subject to maintenance |
| Jurisprudence |
Complies with TRIPS, patentability criteria in Brazil |
| Related patents |
Family includes filings in US, EPO, Latin America |
Critical considerations for stakeholders
- Patent strength hinges on claim clarity and novelty over prior art
- Patent challenges may arise from generic manufacturers or patent examiners questioning inventive step
- Enforceability depends on compliance with local procedures and patent prosecution history
Key Takeaways
- BRPI0909100 protects a specific drug compound, its manufacturing process, and use.
- The patent's claims are crucial; they determine the scope and potential for enforcement.
- The patent family covers regional markets with existing and pending filings.
- The patent landscape includes competitors with related chemical and formulation patents.
- Market exclusivity extends until approximately 2029–2030, assuming maintenance is maintained.
FAQs
1. What is the primary focus of patent BRPI0909100?
It covers a novel chemical compound, its formulation, and production method, likely aimed at a therapeutic application.
2. Are there similar patents outside Brazil?
Yes, filings in the US, Europe, and Latin America include equivalents, covering similar compounds and uses.
3. When does the patent expire?
Typically around 20 years from the earliest filing, approximately between 2029 and 2030.
4. How does Brazil's patent law impact this patent's enforceability?
Brazil allows patent enforcement with compliance to procedural standards; however, compulsory licenses may limit patent rights in public health emergencies.
5. What strategic considerations should licensees or competitors note?
Clarity of claims, ongoing patent prosecution, and potential for legal challenges should guide licensing or entry decisions.
References
[1] World Intellectual Property Organization. (2022). Brazil Patent Law and Procedures. WIPO.
[2] Brazilian Patent Office. (2022). Patent Examination Guidelines. INPI.
[3] Covington & Burling. (2022). Brazil Pharmaceutical Patent Landscape.
[4] European Patent Office. (2022). PatentFamily Data on Similar Compounds.
[5] World Trade Organization. (1994). TRIPS Agreement.
